Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah
Yahoo/Zacks.com
Tue, 05/31/22 - 10:41 am
Tags:
Novartis, FDA, Kymriah, CAR-T, relapsed or refractory follicular lymphoma
Abbvie to become the biggest of pharmas in 2028
EP Vantage
Mon, 05/30/22 - 10:13 am
Tags:
AbbVie, Humira, Pfizer, Novartis, Bristol Myers Squibb, Roche
ASCO: Novartis eyes full nod for Gleevec follow-on Scemblix thanks to new leukemia data
Fierce Pharma
Fri, 05/27/22 - 10:21 am
Tags:
ASCO 2022, Novartis, Gleevec, Scemblix, CML, chronic myeloid leukemia
Bristol Myers Squibb sues Novartis for royalties surrounding the use of transgenic mice
Endpoints
Tue, 05/24/22 - 04:36 pm
Tags:
Bristol Myers Squibb, Novartis, legal, New York, Medarex, transgenic mice
Long-expected UK layoffs imminent for Novartis following sale
Endpoints
Tue, 05/17/22 - 10:28 pm
Tags:
Novartis, UK, layoffs, drug manufacturing
Greece goes on offensive against Novartis, filing a lawsuit in aftermath of bribery scheme
Endpoints
Tue, 05/17/22 - 10:22 pm
Tags:
Novartis, Greece, legal, bribery
Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
Tags:
R&D, licensing, M&A, COVID-19, Big Pharma, Bristol Myers Squibb, JNJ, AbbVie, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Roche, GSK, Eli Lilly
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Tags:
Novartis, Sandoz, generics, Roche, Esbriet, idiopathic pulmonary fibrosis
Two Novartis sites stop manufacturing cancer therapies after quality issues
Endpoints
Thu, 05/5/22 - 11:21 pm
Tags:
Novartis, drug manufacturing, radioligand
Record-breaking 2021 revenue shows there's more to Swiss biotech sector than Roche, Novartis
Fierce Biotech
Wed, 05/4/22 - 10:30 am
Tags:
biotech, Switzerland, Novartis, Roche, Sophia Genetics, CRISPR Therapeutics
Novartis Is Looking for Deals. Are These 3 Biotechs on Its List?
Motley Fool
Mon, 05/2/22 - 11:57 am
Tags:
Novartis, M&A, AveXis, Zolgensma, Endocyte, Pluvicto, The Medicines Company, Levqio
‘Tis the Season: Job Cuts and C-Suite Shifts at Novartis, BridgeBio and Nektar
BioSpace
Wed, 04/27/22 - 10:59 am
Tags:
Novartis, Nektar, BridgeBio, layoffs, restructuring, executives
A bad day for Molecular Partners
EP Vantage
Wed, 04/27/22 - 10:45 am
Tags:
Molecular Partners, MP0310, Amgen, Novartis, ensovibep
Novartis records another tislelizumab win en route to bringing BeiGene's PD-1 to FDA's doors
Endpoints
Wed, 04/27/22 - 10:32 am
Tags:
Novartis, BeiGene, tislelizumab, esophageal cancer
Novartis confirms 'thousands' of layoffs loom as its global reorganization rolls ahead
Fierce Pharma
Tue, 04/26/22 - 10:38 pm
Tags:
Novartis, layoffs, M&A
Novartis income edges higher on strong Sandoz, Entresto
Yahoo/Reuters
Tue, 04/26/22 - 10:23 am
Tags:
Novartis, earnings
Pharma Continues to Support Ukraine as War Rages On
BioSpace
Fri, 04/22/22 - 10:40 am
Tags:
Russia, Ukraine, AbbVie, Novartis, Pfizer
Thousands of layoffs planned as part of Novartis restructuring — report
Endpoints
Tue, 04/12/22 - 11:02 am
Tags:
Novartis, layoffs, restructuring
Novartis Highlights Early Data from Potential Lumakras Competitor at AACR
BioSpace
Tue, 04/12/22 - 10:49 am
Tags:
Novartis, AACR, JDQ443, clinical trials, Amgen, Lumakras
Novartis' PI3K drug, already approved in breast cancer, nabs a speedy OK to treat ultra-rare condition
Endpoints
Wed, 04/6/22 - 12:01 pm
Tags:
Novartis, alpelisib, FDA, RWE, real world evidence, PROs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.